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Colorectal cancer (CRC) screening in the 
Medicare population remains low despite 
Medicare coverage. We describe a popula-
tion-based effort to increase CRC testing of 
Medicare enrollees in two States through pro-
motion and distribution of office-based tools 
to primary care physicians and gastroenterol-
ogists. Small increases in colonoscopy test use 
by primary care physicians were observed, 
but the differences were not statistically sig-
nificant. Results in one State were stronger 
than the other, and two components of the 
intervention appeared more promising than 
others. Use of CRC tests can be increased, but 
additional approaches are needed.
BACKGROUND
Medicare provides coverage for CRC 
screening for average risk enrollees age 50 
or over through four options: a yearly fecal 
occult blood test (FOBT), a flexible sig-
moidoscopy or barium enema once every 4 
years, or a colonoscopy every 10 years. The 
Medicare benefit allows CRC testing with-
in the intervals recommended by the U.S. 
Preventive Services Task Force (USPSTF) 
guidelines (Pignone et al., 2002). However, 
despite insurance coverage, CRC screen-
ing of Medicare enrollees falls below rec-
ommended guidelines (Pham et al., 2005). 
In 2000, CMS funded Quality Improve-
ment Organizations (QIOs) in two States 
(North and South Carolina) to develop, 
pilot-test, and evaluate interventions to 
increase Medicare CRC test use rates. 
Through an interagency agreement with 
CMS, NCI participated with the QIOs in 
evaluating the CRC interventions. A multi-
level approach was designed targeting both 
Medicare consumers and their physicians. 
This article describes and evaluates the 
impact of the physician-level intervention 
on the utilization of CRC screening tests 
for Medicare enrollees. 
The importance of physician recommen-
dation for CRC screening is well docu-
mented (Brawarsky, Brooks, and Mucci, 
2003, Rawl et al., 2000; Lewis and Asch, 
1999; Mandelson et al., 2000; Stockwell 
et al., 2003; Taylor et al., 2003; Vernon, 
1997). Yet, a number of factors constrain 
physicians’ ability to provide CRC test-
ing to their eligible patients including: 
lack of awareness or understanding of 
CRC screening guidelines (Klabunde et 
al., 2003; Sharma et al., 2000; Cabana, et al., 
1999); inadequate reimbursement (Lewis 
and Asch, 1999); lack of a system to iden-
tify those who need testing; lack of patient 
knowledge; and too little time during the 
office visit (Jaen, Stange, and Nutting, 
1994; Yarnall et al., 2003). 
Office-based interventions to increase 
physician use of CRC tests generally target 
one or more of these constraints and, for 
the most part, have shown strong evidence 
of effectiveness (Snell and Buck, 1996; 
Balas et al., 2000; Shea, DuMouchel, and 
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Bahamonde, 1996; Peterson and Vernon, 
2000; Vernon, 1997; Pignone, Harris, and 
Kinsinger, 2000). Why then, if interven-
tions to increase physician CRC testing 
have been developed and shown to work, 
has CRC test use remained low? The rea-
son for the gap may be that most of the 
evidence for efficacy of interventions to 
promote CRC screening comes from aca-
demic or managed care settings, or physi-
cian practices where higher authority or 
peer pressure can be leveraged to encour-
age physician participation. Proving that 
interventions are efficacious in such set-
tings does not guarantee they will be effec-
tive in population–based settings (Glasgow, 
Lichtenstein, and Marcus, 2003). Our study 
examines the outcome of translating clini-
cally proven techniques into low-cost inter-
ventions and delivering those interventions 
to physicians on a population basis. 
MetHODS
Study Design
A quasi-experimental design was used 
with intervention and comparison coun-
ties designated in each State and measure-
ment of CRC test use before and after the 
intervention (Cook and Campbell, 1979). 
Contiguous counties were selected for 
each study group to minimize the likeli-
hood of contamination due to practices with 
multiple sites being assigned to opposite 
study groups. In North Carolina, the selec-
tion process involved identifying the urban 
counties and surrounding counties border-
ing them and selecting one of the areas, 
which consisted of 12 counties, to receive 
the intervention. The remaining identified 
areas, containing 36 counties, serve as the 
comparison group. In South Carolina, 17 
contiguous counties were included in the 
intervention group and 17 similar counties 
were in the comparison group. Intervention 
efforts targeted internal medicine, family 
practice, general practice, and gastroentrol-
ogy physicians in the intervention counties.
The intervention activities occurred over 
the span of 1 year. For this evaluation, July 
2001–June 2002 is treated as the interven-
tion period. In an effort to minimize the 
potential effect of seasonal variations in 
CRC testing, the same calendar quarters, 
one year apart, was selected for measur-
ing the effects of the intervention. The 
baseline period was designated as April 1, 
2001—June 30, 2001; the evaluation period 
was April 1, 2002—June 30, 2002. While the 
evaluation period actually includes the last 
part of the intervention window, the major-
ity of the interventions had already been 
delivered by that time so we felt it likely 
that any impact of the intervention would 
be detectable in the evaluation period. 
Description of the interventions
Two interventions were offered to physi-
cians in both States: telephone-based con-
tinuing medical education and office-based 
tool kits. In South Carolina, two additional 
interventions were piloted with small groups 
of physicians: personalized letters sent by 
the physician to patients encouraging CRC 
testing, and distribution of free FOBT kits 
in physician offices. A brief description of 
each intervention is provided.1 
Continuing Medical Education 
Teleconferences
Two teleconferences with continuing 
medical education credits were conducted 
to educate physicians and their office staff. 
The first teleconference introduced the 
(then) new coverage of colonoscopy screen-
ing for average-risk Medicare enrollees, and 
provided details on all Medicare-covered 
CRC screening tests. Other topics included: 
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1 Further details on the interventions are available on request 
from the authors. 
a discussion of the USPSTF guidelines for 
CRC screening and an introduction of the 
QIO project. The second teleconference 
included information on how to increase 
office-based testing, a review of the tools 
included in the tool kits, and billing proce-
dures for CRC tests under Medicare. The 
teleconferences, lasting 1.5 hours, were 
offered free of charge, and conducted in the 
evening. Participation in the teleconferenc-
es was promoted through direct mail to all 
targeted physicians and FAxed announce-
ments when physician FAx telephone num-
bers were available. Fifty-four physicians 
from both States participated in one or both 
teleconferences.
Office-Based Tool Kits
Physician-office tool kits contained 
office-based interventions shown to be 
successful based on published literature. 
The tool kits included provider and patient 
educational materials from the Centers for 
Disease Control and Prevention Screen for 
Life program, county and State CRC test 
use rates, and a patient education video 
based on stage-of-change theory that had 
been successfully tested in an earlier trial 
(Pignone, Harris, and Kinsinger, 2000). 
The tool kits also included a patient health 
maintenance checklist to be completed by 
the patient at check-in to identify patients 
in need of CRC testing, and chart stickers 
instructing physicians to discuss CRC test-
ing with patients who needed it. The tool 
kits included a CD-ROM with electronic 
files of all the materials (including the 
patient education video). Physicians could 
print copies of any of the tools included in 
the kit. In addition, each tool kit contained 
information about how to order additional 
copies from the State QIO free of charge. 
Tool kits were promoted through direct 
mail and FAxes to all primary care and 
gastroenterology physicians in the inter-
vention counties. Tool kits were shipped to 
physicians (n=181) who ordered them. In 
South Carolina, additional kits were mailed 
to a sample of physicians (n=73) who had 
not ordered them, targeting those in inter-
vention counties where the testing rate for 
Medicare was lower than the State rate.
FOBT Distribution by Physicians
Two clinics agreed to participate in a 
1-month pilot to distribute FOBT kits to 
patients free of charge: a federally quali-
fied health center (FQHC), and a private 
physician office. The State QIO prepared 
simplified instructions for the kits and 
distributed them to participating practices 
who were then asked to give them to eligi-
ble Medicare enrollees visiting the practice 
during the month. Four physicians partici-
pated, distributing a total of 90 FOBT kits.
Physician Letter Mailing
In South Carolina, the QIO invited phy-
sicians to share lists of patient names with 
them so that they could send letters to the 
Medicare patients reminding them of the 
importance of screening. Fourteen physi-
cians in four offices agreed to provide the 
QIO with names of their patients. Names 
were linked to the Medicare enrollment 
database to identify Medicare beneficiaries 
in the intervention counties. A personal-
ized letter from the patient’s physician 
was sent to all identified patients (n=7,726) 
encouraging them to be tested for CRC. 
evAlUAtiON MeASUReS
Medicare inpatient, outpatient, and phy-
sician claims for screening and diagnostic 
CRC tests (FOBT, sigmoidoscopy, colonos-
copy, and barium enemas) were used to 
measure physician testing. Test use was 
analyzed in the aggregate (all CRC tests) 
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and separately by type of test. Claims for 
tests conducted during April–June 2001 
were used to create the baseline testing 
measures; claims for tests in April–June 
2002 were used in the evaluation measure. 
To analyze the effect of the physician 
interventions, we constructed a patient 
test ratio (PTR) measure, which consist-
ed of the number of unique Medicare 
patients for whom the physician referred 
or performed a CRC test per 100 unique 
Medicare patients seen for outpatient eval-
uation or management visits. The PTR 
was modeled after the health maintenance 
ratio of Balas and colleagues (2000). The 
physician unique physician identification 
number (UPIN) on the CRC test claim was 
used to determine the number of CRC tests 
completed. Physicians were credited with a 
CRC test if they were listed as the referring 
or performing physician for a CRC test for 
a Medicare enrollee age 50 and over. The 
Medicare Outpatient Opportunities Files, 
which contain records of visits for new or 
established patients for outpatient services, 
consultation or preventive services, were 
used to determine the number of unique 
Medicare patients age 50 or over seen by 
physicians each quarter. The PTR did not 
require patients included in a physician’s 
numerator to be in the denominator for that 
physician. Thus, there was a potential for 
physicians to be credited with more tests in 
the numerator than patients in the denomi-
nator. To avoid conceptually impossible 
PTRs, we constrained PTRs to the theoreti-
cal maximum of 100 tests per 100 patients. 
When the referring and performing phy-
sicians were different doctors, both were 
credited with a CRC test. Although this 
approach counts tests in more than one 
physician numerator, this is offset by the 
fact that patients can be included in the 
unique patient volume count for more than 
one physician. We chose to credit physi-
cians with referrals as well as actual tests 
conducted because a major goal of the 
intervention was to change the behavior 
of primary care physicians, many of whom 
refer patients to specialists for sigmoid-
oscopy and colonoscopy tests rather than 
perform the tests themselves. To check 
for potential blurring of intervention effect, 
we repeated the analyses using only claims 
for performing CRC tests in the calcuation 
of the PTRs. The results were not substan-
tively different and are available on request 
from the author. 
StAtiStiCAl ANAlYSeS
CRC test use was analyzed using an 
“intention to treat” approach comparing 
test use ratios for targeted physicians in 
intervention counties with those in com-
parison counties for baseline and evalua-
tion periods. Analyses were conducted sep-
arately for gastroenterologists and primary 
care physicians (internists and general 
and family practice physicians). To miti-
gate confounding due to secular trends, 
the impact of the evaluation was assessed 
by calculating the difference of the differ-
ence—that is, the increase in test ratios 
among intervention physicians compared 
with the increase among comparison phy-
sicians. This difference measure, which we 
term intervention effect (IE), represents 
the number of additional tests ordered 
or performed per 100 eligible Medicare 
patients by intervention area physicians 
relative to comparison area physicians. 
The IE is calculated as: 
IE = 
(PTR for intervention county MDs during 
the evaluation period – PTR for interven-
tion county MDs in the baseline period) – 
(PTR for comparison county MDs during 
the evaluation period – PTR for comparison 
county MDs during the baseline period).
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Standard errors of test use ratios were 
calculated using methods appropriate for 
ratios (Cochran, 1977). Statistical signifi-
cance was assessed using z-scores.
Analyses were repeated comparing par-
ticipating with non-participating physicians 
(regardless of their county of practice) to 
assess the effect of participation on CRC 
testing rates. The IE was calculated using 
PTRs from participating and non-partici-
pating physicians during the baseline and 
evaluation periods. These analyses were 
conducted separately for participation in 
any part of the intervention and separately 
by intervention component.
ReSUltS
The intervention counties contained 
2,724 physicians (Table 1) The majority 
of targeted physicians were internists, fol-
lowed by family and general practioners. 
Gastroentrologist comprised 5.8 percent 
of the targeted physicians. Most physi-
cians were solo pratictioners or practiced 
in groups of less than 10 physicians. The 
average number of Medicare patients seen 
per month ranged from 59.3–80.5 patients/
month across the intervention and com-
parison areas.
A total of 282 participating physicians 
were available for analyses (Table 2) rep-
resenting 10.4 percent of those targeted 
by the study design. Actual participation in 
the interventions was greater, however, not 
all participating physicians could be linked 
to the claims data to be used for evaluation. 
The main reasons participants could not be 
tracked for evaluation were that the UPIN 
was unknown, the physician practiced in a 
non-targeted specialty, or the physician did 
not have any Medicare visits during the 
study window. In addition, a few physicians 
from control counties in both States partici-
pated in the interventions (total n=9). 
Baseline CRC testing by primary care 
physicians ranged from 6.6-7.9 tests per 
100 patients for any CRC test (Table 3) 
across both States and study groups. 
Gastroenterologists had considerably high-
er baseline PTRs for any CRC test: 58.5-66.5 
tests per 100 patients across both States 
Table 1
Characteristics of Physician Populations in Study Areas1
	 North	Carolina	 South	Carolina	
	 Intervention	 Control	 Intervention	 Control
Characteristic	 N	(%)	 N	(%)	 N	(%)	 N	(%)
Physicians	Overall	 1,408	 3,257	 1,316	 1,307
Speciality
Internal	Medicine		 802	(57.0)	 1,606	(49.3)	 636	(48.3)	 538	(41.2)
Family	and	General	Practice		 528	(37.5)	 1,473	(45.2)	 601	(45.7)	 725	(55.5)
Gastroenterology		 78	(5.5)	 178	(5.5)	 79	(6.0)	 44	(3.4)
Practice Size     
Solo		 324	(23.1)	 715	(22.0)	 304	(23.1)	 195	(14.9)
2–5		 320	(22.7)	 955	(29.3)	 322	(24.5)	 380	(29.1)
6–10		 156	(11.1)	 469	(14.4)	 154	(11.7)	 181	(13.9)
11–25		 43	(3.1)	 326	(10.0)	 204	(15.5)	 124	(9.5)
>	25		 276	(19.6)	 256	(7.9)	 226	(17.2)	 363	(27.8)
Unknown	 289	(20.5)	 536	(16.5)	 106	(8.1)	 64	(4.9)
Practice    
Rural	 161	(11.4)	 633	(19.4)	 315	(23.9)	 323	(24.7)
Urban	 1,247	(88.6)	 2,624	(80.6)	 1,001	(76.1)	 984	(75.3)
Average	Number	of	Monthly	Medicare	Patient	Visits	 59.3	 73.2	 72.2	 80.5
1	Physicians	were	included	in	the	study	group	counts	if	they	had	at	least	one	claim	for	a	Medicare	patient	during	a	1-year	period.
SOURCE:	Centers	for	Medicare	&	Medicaid	Services:	Program	Resource	System,	2005.
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and study groups. Primary care physicians 
were more likely to test using FOBT (PTRs 
= 4.4-5.6 tests per 100 patients) whereas 
gastroenterologists conducted more colo-
noscopy exams (PTRs = 46.1-56.7 tests per 
100 patients).
In the intention to treat analyses, the IE 
among primary care physicians showed 
small decreases in use of FOBT and any 
CRC test, and a slight increase in the use 
of colonoscopy in both States (Table 3) 
although none of the changes were sta-
tistically significant. Among gastroenter-
ologists, larger intervention effects were 
observed although only in South Carolina. 
CRC testing by gastroenterologists in South 
Carolina intervention counties increased 
more than testing by gastroenterologists in 
comparison counties for FOBT, sigmoidos-
copy, colonoscopy, and any test. The IE for 
any test for gastroenterologists in South 
Carolina was 8.96 tests per 100. None of 
the IEs observed in South Carolina gastro-
enterologists were statistically significant. 
The analyses by participation status pro-
duced similar results (Table 4). Again, no 
statistically significant participation effects 
were observed, although small increases in 
colonoscopy were observed in both States 
for primary care providers (North Carolina 
IE=0.33, South Carolina IE=0.83) and larger 
IEs were observed among South Carolina 
gastroenterologists (IE=7.1 for any CRC 
test). 
Analyses of the separate intervention 
components was hampered by the small 
number of participants in some of the 
interventions. Two components of the 
intervention showed some evidence of 
effectiveness. In South Carolina, partici-
pants in teleconferences appeared to have 
increased CRC testing (primary care phy-
sicians IE= 5.3 tests per 100 Medicare 
patients, p > 0.05 and gastroenterologists 
IE=14.4 tests per 100 Medicare patients, 
z-square=8.27, p=0.0059). Similarly, sharing 
patient data with the QIO to mail letters 
to patients appeared effective for increas-
ing FOBT (IE=1.1 tests per 100 Medicare 
patients, z-square=3.64, p=0.056). However, 
the number of physicians participating 
in these two interventions was small and 
overlapped with other interventions, mak-
ing it difficult to determine the source of 
the improvement in CRC test use. There 
was no meaningful difference in the change 
in CRC testing among physicians who 
ordered tool kits compared to the physi-
cians randomly selected to receive a tool 
kit by mail, and no increase in CRC testing 
by physicians who distributed FOBT kits.
DiSCUSSiON
Our study pilot-tested four interven-
tions designed to increase CRC testing of 
Medicare enrollees by primary care and 
gastroenterology physicians. We found rel-
atively low levels of CRC test use at base-
line and low interest in CRC interventions 
among primary care physicians. Although 
the interventions were free to participating 
physicians, only 10 percent of the primary 
care physicians we targeted responded to 
Table 2
Number of Physicians Participating in Any Component of Intervention, by State and Specialty: 
2001-2002
	 North	Carolina	 South	Carolina	 Total
Speciality	 Number	 Percent	of	target	 Number	 Percent	of	target	 Number	 Percent	of	target
Primary	Care	 95	 7.1	 160	 12.9	 255	 9.9
Gastroenterology	 14	 17.9	 13	 16.4	 27	 17.2
Total	 109	 7.7	 173	 13.1	 282	 10.4
SOURCES:	Schenck,	A.P.,	Gunter,	N.,	Peacock,	S.,	and	Jackson,	E.,	The	Carolinas	Center	for	Medical	Excellence,	Pignone,	M.,	University	of	North	
Carolina	Department	of	Medicine,	Klabunde,	C.N.,	National	Cancer	Institute,	2005.
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the invitations to participate. As might be 
expected, the test use and interest in par-
ticipation among gastroenterologists was 
higher, with 17.2 percent participation.
No statistically significant intervention 
effects were observed for increase in test-
ing for any of the CRC tests. In both 
States, a small, positive IE was observed 
among primary care physicians for colo-
noscopy (North Carolina IE=0.23, South 
Carolina IE=0.20) in the intention to treat 
analyses, and slightly larger effects for 
colonoscopy in the analyses of participants 
(North Carolina IE=0.33, SC IE=0.83). 
Small changes in testing such as observed 
here could translate into important public 
health gains if implemented on a population 
wide basis. For example, if an interven-
tion effect of 2 colonoscopy tests per 1,000 
Medicare enrollees (or 0.20 tests per 100, 
as was found here) were implemented for 
the entire eligible Medicare populations in 
both States, it could result in approximately 
3,000 additional colonoscopy procedures. 
In South Carolina, the observed increase 
for all CRC tests among gastroenterolo-
gists, while not statistically significant, may 
have clinical impact, depending on the 
numbers of Medicare enrollees seen by 
the gastroenterologists. This increase may 
be a result of changes on the part of the 
gastroenterology physicians, or may be 
reflective of additional referrals from pri-
mary care providers. 
The evaluation of these interventions 
was challenging for a number of reasons. 
We relied on claims to measure tests, yet 
the validity of Medicare claims to assess 
FOBT use has been questioned (Engleman 
et al., 2001), since some providers may 
not submit claims for such low-reimburse-
ment tests. Sigmoidoscopy and colonos-
copy claims are thought to be accurate, 
however, it is unclear how quickly patients 
are able to get appointments for testing, 
so some effects of the interventions may 
have been missed. By relying on claims, 
we only count completed tests, and miss 
changes that may have occurred if phy-
sicians increased their ordering of the 
tests, but patients failed to comply with 
the recommendation. Another measure-
ment obstacle was the variation that we 
found in CRC test use by physicians. The 
test use ratios ranged from 0-100 tests per 
100 Medicare patients. The wide variation 
made it difficult to attribute changes to 
interventions and for changes in test use to 
achieve statistical significance. 
At the time these interventions were test-
ed, Medicare had just implemented screen-
ing colonoscopy for average risk enrollees, 
the updated USPSTF guidelines were not 
yet published and a Health Plan Employer 
Data and Information Set (HEDIS®) mea-
sure for colorectal cancer screening had 
not been implemented. Attention to CRC 
has grown since that time. Although inter-
est and awareness among primary care pro-
viders would likely be greater if the study 
were implemented today, physicians face 
many barriers in trying to promote CRC 
testing, including competing demands on 
their time, concerns about reimbursement, 
and patient compliance.
Physicians who participated in the inter-
ventions were already providing CRC test-
ing at a higher level than non-participants. 
This was true for both primary care and 
gastroenterologists. This may be reflective 
of a higher interest or ability to provide pre-
ventive services in the first place. Creative 
approaches and extraordinary recruiting 
efforts will be needed to promote any CRC 
physician intervention and encourage par-
ticipation in CRC physician interventions, 
particularly if we hope to reach lower per-
forming physicians.
Two of the interventions tested showed 
promise: the letters from physicians to 
their patients and teleconferences. The 
letters to patients were offered only in 
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South Carolina. However, the teleconfer-
ences were offered in both States—yet an 
effect was only observed in South Carolina. 
Whether the differential effects observed 
across States are due to differences among 
the participants or the combination of 
interventions cannot be determined from 
this study. 
The results of this study imply that 
additional work is needed to translate what 
is known to work in clinical settings into 
widespread use. We need to know how to 
engage more physicians with CRC test-
ing and we need approaches that produce 
larger changes in CRC test use.
Although the effectiveness of CRC test-
ing in reducing colorectal cancer mortality 
has been documented (Pignone, 2002) and 
the burden colorectal cancer places on 
the Medicare population is known, in the 
5 years following the introduction of the 
screening benefit, less than one-half of the 
Medicare population had a CRC test of any 
kind (The Carolinas Center for Medical 
Excellence, 2005). Medicare coverage of 
CRC screening tests provides the Medicare 
Program with an excellent opportunity to 
prevent mortality and morbidity associated 
with colorectal cancer. This opportunity 
will be lost, however, if we cannot increase 
CRC testing among Medicare consumers. 
Increasing physician use of the tests is only 
part of the equation—educating Medicare 
beneficiaries is also needed. The inter-
ventional approaches used in this study 
did not provide a ready solution. New 
efforts are needed to better understand 
how to achieve increased CRC testing in 
the Medicare population. 
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